Featuring Rob Engel, General Counsel at DeepIntent and board member of the Network Advertising Initiative, with guest host Nathan Lenyszyn, Chief Marketing Officer and Head of Privacy at HealthLink Dimensions.

As AI moves to the center of healthcare marketing, what separates the companies that build privacy into the foundation from the ones still treating compliance as the department that says no?

In this special privacy and compliance episode of HealthLink Signals, guest host Nathan Lenyszyn sits down with Rob Engel, General Counsel at DeepIntent and a board member of the Network Advertising Initiative, to examine why privacy and governance have become a competitive advantage in healthcare advertising rather than a constraint on it.

Drawing on a career that began in healthcare data and moved into adtech, Rob explains why the hard-won muscle of navigating a patchwork of state privacy laws now sets experienced companies apart, how AI shifted from something data partners once banned to something central to the work, and why the governance layer between powerful general AI tools and sensitive data is where trust is either kept or lost.

Compliance in healthcare media is no longer a cost of doing business. It is a signal of who can be trusted with data, and increasingly it is the thing that separates the companies built to last from the ones built to scale.

In this conversation, Engel discusses:

• Why compliance complexity is a tailwind for experienced companies, not a headwind
• How to tell whether a partner has privacy built in: when legal, product, and commercial teams are already in sync
• Why HIPAA is a baseline for healthcare marketing, not the whole standard
• What changes when general AI tools sit on top of sensitive data, and where the governance layer belongs
• How shared accountability across the ecosystem separates real partners from the ones who just talk about it

He also reflects on the belief about risk and data he has had to rethink most over his career, and offers a sharp test for whether you can really trust a partner: would you be willing to buy their company?